Major Initiatives

The Takeda Initiative (2010–2019)

On March 18, 2010, Takeda Pharmaceutical and the Global Fund announced an exciting new partnership in which Takeda will contribute ¥1 billion (approximately US$10 million) over 10 years for the Global Fund’s programs, with a focus on its work in Africa for health system strengthening and human capacity development initiatives. Takeda is one of the first Japanese companies to make such a major financial contribution to addressing an important global challenge.

Tadashi Yamamoto, then president of JCIE and director of the FGFJ, which helped facilitate the partnership, commented on the commitment: “Takeda’s contribution is truly groundbreaking. It is one of the first times that a Japanese company is taking such a leading role in the global fight against these three diseases. It provides an exemplary model of how diverse sectors of society in Japan can actively contribute more to global challenges such as deadly communicable diseases.”


Objectives of the Takeda Initiative

Takeda Initiative

  1. To support human capacity development for health system strengthening in developing countries. As the first phase of the initiative, Takeda is supporting the following Global Fund projects in Africa:
    • Tanzania (target disease: malaria)
      National Insecticide Treated Nets Implementation Plan (NATNETS)
      —Strengthening the system for distributing insecticide-treated nets and developing the human resources engaged in promoting the use and dissemination of nets
    • Nigeria (target disease: HIV/AIDS)
      Scale-up of comprehensive HIV/AIDS treatment, care, and support
      — Training of staff members of not-for-profit and grassroots organizations engaged in providing community-based care for HIV/AIDS patients and orphans, and carrying out advocacy and awareness-raising activities
    • Kenya (target disease: tuberculosis)
      Reinforcement of TB control
      — Capacity development for health workers engaged in tuberculosis diagnosis and treatment
  2. To support the Global Fund in its public relations and advocacy activities in Japan


For more information

Global Fund press announcement: English / Japanese
Takeda Pharmaceutical Company announcement